within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01A_AlkylatingAgents.L01AD05_Fotemustine;
model Fotemustine 
   extends Pharmacolibrary.Drugs.ATC.L.L01AD05;

  annotation(Documentation(
    info ="<html><body><p>Fotemustine is an alkylating antineoplastic agent of the nitrosourea class, used primarily in the treatment of malignant melanoma, especially with metastases to the brain, and sometimes for primary brain tumors. It is approved in some European countries but not in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult cancer patients (malignant melanoma) after intravenous administration.</p><h4>References</h4><ol><li><p>Marzolini, C, et al., &amp; Lejeune, F (1998). Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. <i>Cancer chemotherapy and pharmacology</i> 42(6) 433–440. DOI:<a href=&quot;https://doi.org/10.1007/s002800050842&quot;>10.1007/s002800050842</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9788568/&quot;>https://pubmed.ncbi.nlm.nih.gov/9788568</a></p></li><li><p>Cour, V, &amp; Langenbahn, H (1990). [Fotemustine, a new nitrosourea derivative. Current status of development]. <i>Onkologie</i> 13(1) 7–11. DOI:<a href=&quot;https://doi.org/10.1159/000216710&quot;>10.1159/000216710</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2186326/&quot;>https://pubmed.ncbi.nlm.nih.gov/2186326</a></p></li><li><p>Fety, R, et al., &amp; Vignoud, J (1992). Hepatic intra-arterial infusion of fotemustine: pharmacokinetics. <i>Cancer chemotherapy and pharmacology</i> 31(2) 118–122. DOI:<a href=&quot;https://doi.org/10.1007/BF00685097&quot;>10.1007/BF00685097</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1451232/&quot;>https://pubmed.ncbi.nlm.nih.gov/1451232</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Fotemustine;
